Logo image of RVTY

REVVITY INC (RVTY) Stock Fundamental Analysis

NYSE:RVTY - US7140461093 - Common Stock

85.04 USD
-0.96 (-1.12%)
Last: 9/9/2025, 5:16:02 PM
85.04 USD
0 (0%)
After Hours: 9/9/2025, 5:16:02 PM
Fundamental Rating

6

Taking everything into account, RVTY scores 6 out of 10 in our fundamental rating. RVTY was compared to 55 industry peers in the Life Sciences Tools & Services industry. While RVTY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. RVTY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year RVTY was profitable.
RVTY had a positive operating cash flow in the past year.
In the past 5 years RVTY has always been profitable.
In the past 5 years RVTY always reported a positive cash flow from operatings.
RVTY Yearly Net Income VS EBIT VS OCF VS FCFRVTY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

RVTY's Return On Assets of 2.31% is fine compared to the rest of the industry. RVTY outperforms 67.27% of its industry peers.
Looking at the Return On Equity, with a value of 3.77%, RVTY is in the better half of the industry, outperforming 67.27% of the companies in the same industry.
With a decent Return On Invested Capital value of 2.70%, RVTY is doing good in the industry, outperforming 63.64% of the companies in the same industry.
RVTY had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 15.96%.
Industry RankSector Rank
ROA 2.31%
ROE 3.77%
ROIC 2.7%
ROA(3y)3.77%
ROA(5y)5.35%
ROE(3y)6.68%
ROE(5y)10.55%
ROIC(3y)3.45%
ROIC(5y)6.13%
RVTY Yearly ROA, ROE, ROICRVTY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 10.19%, RVTY is in the better half of the industry, outperforming 74.55% of the companies in the same industry.
RVTY's Profit Margin has improved in the last couple of years.
The Operating Margin of RVTY (14.29%) is better than 72.73% of its industry peers.
RVTY's Operating Margin has improved in the last couple of years.
The Gross Margin of RVTY (55.93%) is better than 70.91% of its industry peers.
RVTY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.29%
PM (TTM) 10.19%
GM 55.93%
OM growth 3Y-24.12%
OM growth 5Y2.06%
PM growth 3Y-26.42%
PM growth 5Y4.45%
GM growth 3Y-4.25%
GM growth 5Y2.89%
RVTY Yearly Profit, Operating, Gross MarginsRVTY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

RVTY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, RVTY has less shares outstanding
Compared to 5 years ago, RVTY has more shares outstanding
Compared to 1 year ago, RVTY has an improved debt to assets ratio.
RVTY Yearly Shares OutstandingRVTY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
RVTY Yearly Total Debt VS Total AssetsRVTY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.40 indicates that RVTY is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of RVTY (2.40) is better than 65.45% of its industry peers.
The Debt to FCF ratio of RVTY is 6.39, which is on the high side as it means it would take RVTY, 6.39 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of RVTY (6.39) is better than 63.64% of its industry peers.
RVTY has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
RVTY's Debt to Equity ratio of 0.43 is in line compared to the rest of the industry. RVTY outperforms 41.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.39
Altman-Z 2.4
ROIC/WACC0.29
WACC9.46%
RVTY Yearly LT Debt VS Equity VS FCFRVTY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 3.33 indicates that RVTY has no problem at all paying its short term obligations.
RVTY's Current ratio of 3.33 is in line compared to the rest of the industry. RVTY outperforms 56.36% of its industry peers.
A Quick Ratio of 2.75 indicates that RVTY has no problem at all paying its short term obligations.
With a Quick ratio value of 2.75, RVTY perfoms like the industry average, outperforming 58.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.33
Quick Ratio 2.75
RVTY Yearly Current Assets VS Current LiabilitesRVTY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.62% over the past year.
The Earnings Per Share has been growing slightly by 3.63% on average over the past years.
RVTY shows a small growth in Revenue. In the last year, the Revenue has grown by 3.33%.
Measured over the past years, RVTY shows a decrease in Revenue. The Revenue has been decreasing by -0.91% on average per year.
EPS 1Y (TTM)5.62%
EPS 3Y-24.58%
EPS 5Y3.63%
EPS Q2Q%-3.28%
Revenue 1Y (TTM)3.33%
Revenue growth 3Y-10.38%
Revenue growth 5Y-0.91%
Sales Q2Q%4.1%

3.2 Future

RVTY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.90% yearly.
RVTY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.61% yearly.
EPS Next Y1.47%
EPS Next 2Y6.07%
EPS Next 3Y7.96%
EPS Next 5Y9.9%
Revenue Next Year3.49%
Revenue Next 2Y3.94%
Revenue Next 3Y4.67%
Revenue Next 5Y4.61%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RVTY Yearly Revenue VS EstimatesRVTY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
RVTY Yearly EPS VS EstimatesRVTY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.39, which indicates a rather expensive current valuation of RVTY.
Based on the Price/Earnings ratio, RVTY is valued cheaply inside the industry as 85.45% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of RVTY to the average of the S&P500 Index (27.07), we can say RVTY is valued slightly cheaper.
RVTY is valuated correctly with a Price/Forward Earnings ratio of 15.42.
Based on the Price/Forward Earnings ratio, RVTY is valued cheaply inside the industry as 87.27% of the companies are valued more expensively.
RVTY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.59.
Industry RankSector Rank
PE 17.39
Fwd PE 15.42
RVTY Price Earnings VS Forward Price EarningsRVTY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RVTY is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RVTY indicates a rather cheap valuation: RVTY is cheaper than 85.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.62
EV/EBITDA 15.02
RVTY Per share dataRVTY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RVTY does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of RVTY may justify a higher PE ratio.
PEG (NY)11.87
PEG (5Y)4.79
EPS Next 2Y6.07%
EPS Next 3Y7.96%

6

5. Dividend

5.1 Amount

RVTY has a yearly dividend return of 0.33%, which is pretty low.
Compared to an average industry Dividend Yield of 0.55, RVTY pays a better dividend. On top of this RVTY pays more dividend than 85.45% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.46, RVTY's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.33%

5.2 History

The dividend of RVTY has a limited annual growth rate of 0.31%.
RVTY has paid a dividend for at least 10 years, which is a reliable track record.
RVTY has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.31%
Div Incr Years0
Div Non Decr Years23
RVTY Yearly Dividends per shareRVTY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

RVTY pays out 11.88% of its income as dividend. This is a sustainable payout ratio.
The dividend of RVTY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP11.88%
EPS Next 2Y6.07%
EPS Next 3Y7.96%
RVTY Yearly Income VS Free CF VS DividendRVTY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
RVTY Dividend Payout.RVTY Dividend Payout, showing the Payout Ratio.RVTY Dividend Payout.PayoutRetained Earnings

REVVITY INC

NYSE:RVTY (9/9/2025, 5:16:02 PM)

After market: 85.04 0 (0%)

85.04

-0.96 (-1.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-28 2025-07-28/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners98.76%
Inst Owner ChangeN/A
Ins Owners0.31%
Ins Owner Change2.59%
Market Cap9.87B
Analysts77.69
Price Target123.07 (44.72%)
Short Float %5.39%
Short Ratio4.87
Dividend
Industry RankSector Rank
Dividend Yield 0.33%
Yearly Dividend0.28
Dividend Growth(5Y)0.31%
DP11.88%
Div Incr Years0
Div Non Decr Years23
Ex-Date10-17 2025-10-17 (0.07)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.88%
Min EPS beat(2)1.51%
Max EPS beat(2)4.25%
EPS beat(4)4
Avg EPS beat(4)4.69%
Min EPS beat(4)1.51%
Max EPS beat(4)11.44%
EPS beat(8)7
Avg EPS beat(8)3.84%
EPS beat(12)10
Avg EPS beat(12)2.32%
EPS beat(16)14
Avg EPS beat(16)6.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.6%
Revenue beat(4)0
Avg Revenue beat(4)-1.28%
Min Revenue beat(4)-1.76%
Max Revenue beat(4)-0.6%
Revenue beat(8)1
Avg Revenue beat(8)-1.64%
Revenue beat(12)1
Avg Revenue beat(12)-7.32%
Revenue beat(16)4
Avg Revenue beat(16)-2.69%
PT rev (1m)0%
PT rev (3m)-4.29%
EPS NQ rev (1m)-0.35%
EPS NQ rev (3m)-9.84%
EPS NY rev (1m)-1.17%
EPS NY rev (3m)-1.11%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.39
Fwd PE 15.42
P/S 3.53
P/FCF 19.62
P/OCF 16.88
P/B 1.31
P/tB N/A
EV/EBITDA 15.02
EPS(TTM)4.89
EY5.75%
EPS(NY)5.51
Fwd EY6.48%
FCF(TTM)4.33
FCFY5.1%
OCF(TTM)5.04
OCFY5.92%
SpS24.11
BVpS65.1
TBVpS-13.55
PEG (NY)11.87
PEG (5Y)4.79
Profitability
Industry RankSector Rank
ROA 2.31%
ROE 3.77%
ROCE 3.42%
ROIC 2.7%
ROICexc 2.95%
ROICexgc 20.12%
OM 14.29%
PM (TTM) 10.19%
GM 55.93%
FCFM 17.97%
ROA(3y)3.77%
ROA(5y)5.35%
ROE(3y)6.68%
ROE(5y)10.55%
ROIC(3y)3.45%
ROIC(5y)6.13%
ROICexc(3y)3.75%
ROICexc(5y)6.55%
ROICexgc(3y)27.62%
ROICexgc(5y)43.67%
ROCE(3y)4.37%
ROCE(5y)7.76%
ROICexcg growth 3Y-28.81%
ROICexcg growth 5Y-3.08%
ROICexc growth 3Y-26.85%
ROICexc growth 5Y-10.99%
OM growth 3Y-24.12%
OM growth 5Y2.06%
PM growth 3Y-26.42%
PM growth 5Y4.45%
GM growth 3Y-4.25%
GM growth 5Y2.89%
F-Score8
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.39
Debt/EBITDA 3.96
Cap/Depr 19.77%
Cap/Sales 2.92%
Interest Coverage 250
Cash Conversion 71.93%
Profit Quality 176.36%
Current Ratio 3.33
Quick Ratio 2.75
Altman-Z 2.4
F-Score8
WACC9.46%
ROIC/WACC0.29
Cap/Depr(3y)19.72%
Cap/Depr(5y)23.7%
Cap/Sales(3y)2.9%
Cap/Sales(5y)2.67%
Profit Quality(3y)102.05%
Profit Quality(5y)111.41%
High Growth Momentum
Growth
EPS 1Y (TTM)5.62%
EPS 3Y-24.58%
EPS 5Y3.63%
EPS Q2Q%-3.28%
EPS Next Y1.47%
EPS Next 2Y6.07%
EPS Next 3Y7.96%
EPS Next 5Y9.9%
Revenue 1Y (TTM)3.33%
Revenue growth 3Y-10.38%
Revenue growth 5Y-0.91%
Sales Q2Q%4.1%
Revenue Next Year3.49%
Revenue Next 2Y3.94%
Revenue Next 3Y4.67%
Revenue Next 5Y4.61%
EBIT growth 1Y8.44%
EBIT growth 3Y-32%
EBIT growth 5Y1.13%
EBIT Next Year12.37%
EBIT Next 3Y9.01%
EBIT Next 5Y11.55%
FCF growth 1Y215.71%
FCF growth 3Y-25.52%
FCF growth 5Y13.93%
OCF growth 1Y157.24%
OCF growth 3Y-23.63%
OCF growth 5Y11.57%